Bioceres Crop Solutions Corp
NASDAQ:BIOX
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1.27
7.22
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Bioceres Crop Solutions Corp
Bioceres Crop Solutions Corp. engages in the provision of crop productivity solutions. The company is headquartered in Rosario, Santa Fe. The company went IPO on 2018-03-22. The Company’s solutions include seeds, seed traits, seed treatments, biologicals, adjuvants and fertilizers. Through its subsidiary Rizobacter, it operates through Brazil and Paraguay. Through the Rizobacter brand, it produces and sells soybean biologicals.
Bioceres Crop Solutions Corp. engages in the provision of crop productivity solutions. The company is headquartered in Rosario, Santa Fe. The company went IPO on 2018-03-22. The Company’s solutions include seeds, seed traits, seed treatments, biologicals, adjuvants and fertilizers. Through its subsidiary Rizobacter, it operates through Brazil and Paraguay. Through the Rizobacter brand, it produces and sells soybean biologicals.
Revenue Decline: Quarterly revenue dropped 17% year-over-year to $77.5 million, mainly due to a planned business model shift and slower sales in key markets.
Gross Margin Expansion: Despite lower revenue, gross profit was stable at $36.2 million, with gross margin rising sharply by 650 basis points to 47%.
Cost Reduction Success: SG&A expenses—both variable and fixed—fell significantly, achieving half of the targeted annualized savings in just one quarter.
Profitability Improvement: Adjusted EBITDA rose 61% to $13.6 million, with the EBITDA margin doubling compared to fiscal 2025.
Debt Down, Liquidity Managed: Total financial debt decreased to $242.5 million, and net debt remained stable, with the company actively managing liquidity amid a debt dispute.
Guidance Reiteration: The company reiterated its focus on operating above 40% gross margin, reducing working capital, and keeping SG&A savings on track.
